The androgen receptor (AR) plays a pivotal role in male physiological development and is implicated in the pathogenesis of various diseases, including prostate cancer. Its N-terminal domain (NTD), characterized by intrinsic disorder, is essential for transcriptional activation. Despite its importance, the precise mechanisms by which the NTD regulates AR's DNA-binding activity remain incompletely understood. This research elucidates the allosteric control mediated by specific NTD subregions-the N-terminal region (NR) and the C-terminal region (CR)-over the DNA binding properties of a truncated AR construct comprising the DNA-binding and ligand-binding domains (ΔNTD-AR). Microscale Thermophoresis (MST) and single-molecule fluorescence imaging were employed to investigate these interactions. This study demonstrates that the NTD subregions exert differential modulatory effects on the kinetics and affinity of ΔNTD-AR binding to DNA. MST analyses indicated that CR reduces ΔNTD-AR DNA binding affinity concentration-dependently, whereas NR did not significantly alter affinity. Single-molecule investigations revealed NR accelerates dissociation, while CR markedly diminishes binding frequency and accelerates dissociation. Combined NR and CR exerted complex effects, synergistically reducing affinity at high concentrations and altering kinetics distinctively compared to individual subregions. Collectively, these results delineate distinct functional roles for the NR and CR subregions in allosterically modulating AR-DNA interactions. This detailed understanding of intrinsic AR regulation offers mechanistic insights into receptor function and highlights potential allosteric sites for therapeutic intervention.
Polycystic ovary syndrome (PCOS) is often linked with immune dysregulation and chronic inflammation, where immune responses play a significant role. Recent studies have identified IGFBP7 involvement in immune processes, suggesting its potential role in modulating immune function. However, the involvement of IGFBP7 in immune modulation within the context of PCOS remains underexplored. In this study, we utilized a Dehydroepiandrosterone (DHEA)-induced PCOS mouse model, including both wild-type and IGFBP7 knockout (KO) mice, to investigate the involvement of IGFBP7 in immune regulation related to PCOS. We performed spleen transcriptome sequencing and TCR β CDR3 repertoire sequencing to assess changes in immune gene expression and T cell receptor diversity. Our findings demonstrate that IGFBP7-/- significantly mitigates PCOS-like symptoms, normalizing estrous cycles and improving ovarian morphology. Transcriptome analysis revealed a substantial downregulated genes in the spleen of IGFBP7-/- mice, with enrichment in pathways associated with immune function. Additionally, in the DHEA-induced PCOS mouse model, TCR β CDR3 repertoire analysis indicated increased clonality and decreased diversity, alongside alterations in V and J gene usage in IGFBP7-/- mice. These results highlight the critical role of IGFBP7 in immune regulation within the context of PCOS, offering new insights into the immune mechanisms underlying PCOS pathology.

